Risk of radiation-related subsequent malignant tumors in survivors of Ewing’s sarcoma

Journal of the National Cancer Institute

Volumn 62, Issue 6, 1979, Pages 1401-1406

  Strong, Louise C ^a   Herson, Jay ^b   Osborne, Barbara M ^b   Sutow, Wataru W ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; VINCRISTINE;

BONE; CANCER CHEMOTHERAPY; CANCER RISK; ETIOLOGY; EWING SARCOMA; MAJOR CLINICAL STUDY; RADIATION CARCINOGENESIS; THERAPY;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; DERMATOFIBROMA; FEMALE; HUMAN; INFANT; MALE; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, RADIATION-INDUCED; OSTEOSARCOMA; RADIOTHERAPY DOSAGE; RISK; SARCOMA, EWING'S; SKIN NEOPLASMS; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0018763572     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/62.6.1401     Document Type: Article

References (52)

1. Li FP, CASSADY JR, JAFFE N: Risk of second tumors in survivors of childhood cancer. Cancer 35:1230-1235, 1975
2. REIMER RR, HOOVER R, FRAUMENI JF JR, et al: Acute leukemia after alkylating-agent therapy of ovarian cancer. N Engl J Med 297:177-181, 1977
3. STRONG LC: Theories of pathogenesis: Mutation and cancer. In The Genetics of Human Cancer (Mulvihill JJ, Miller RW, Fraumeni JF Jr, eds). New York: Raven Press, 1977, pp 401-414
4. STRONG LC: Genetic and environmental interactions. Cancer 40: 1861-1866, 1977
5. CUTLER SJ, YOUNG JL, Jr.: Third National Cancer Survey: Incidence Data. Natl Cancer Inst Monogr 41:1-454, 1975
6. KAPLAN EL, MEIER P: Nonparametric estimations from incom plete observations. J Am Stat Assoc 53:457-481, 1958
7. GEHAN EA: A generalized Wilcoxon test for comparing arbitrari ly singly-censored samples. Biometrika 52:203-223, 1965
8. Advisory Committee on the Biological Effects of Ionizing Radia tion, National Academy of Sciences-National Research Council: The BEIR Report. The Effects of Populations of Exposure to Low Levels of Ionizing Radiation. Washington, D.C.: U.S. Govt Print Off, 1972
9. FERNANDEZ CH, LINDBERG RD, SUTOW WW, et al: Localized Ewing’s sarcoma-treatment and results. Cancer 34:143-148, 1974
10. CHAN RC, SUTOW WW, LINDBERG RD, et al: Management and results of localized Ewing’s sarcoma. Cancer. In press
11. GLASS AG, FRAUMENI JF, Jr.: Epidemiology of bone cancer in children. J Natl Cancer Inst 44:187-199, 1970
12. LARSSON SE, BOQUIST L, BERGDAHL L: Ewing’s sarcoma. Clin Orthop 95:263-272, 1973
13. PRITCHARD DJ, DAHLIN DC, DAUPINE RT, et al: Ewing’s sar coma-a clinicopathological and statistical anaylsis of patients surviving five years or longer. J Bone Joint Surg [Am] 57A:10-16, 1975
14. POMEROY TC, JOHNSON RE: Prognostic factors for survival in Ewing’s sarcoma. AJR 123:598-606, 1975
15. HUTTER RV, FOOTE FW JR, FRANCIS KC, et al: Primitive multi potential primary sarcoma of bone. Cancer 19:1-25, 1966
16. BOSTON HC, Jr., DAHLIN DC, IVINS JC, et al: Malignant lymp homa (so-called reticulum cell sarcoma) of bone. Cancer 34: 1131-1137, 1974
17. CAHAN WG, WOODARD HQ, HIGINBOTHAM NL, et al: Sarcoma arising in irradiated bone. Report of eleven cases. Cancer 1:329, 1948
18. SAGERMAN RH, CASSADY JR, TRETTER P, et al: Radiation in duced neoplasia following external beam therapy for children with retinoblastoma. AJR 105:529-535, 1969
19. POLEDNAK AP: Bone cancer among female radium dial workers. Latency periods and incidence rates by time after exposure. J Natl Cancer Inst 60:77-82, 1978
20. JABLON S, KATO H: Studies of the mortality of A-bomb survivors. Radiat Res 50:649-698, 1972
21. HASELOW RE, NESBIT M, DEHNER LP, et al: Second neoplasms following megavoltage radiation in a pediatric population. Cancer 42:1185-1191, 1978
22. POLEDNAK AP, STEHNEY AF, ROWLAND RE: Mortality among women first employed before 1930 in the U.S. radium dial-painting industry. A group ascertained from employment lists. Am J Epidemiol 107:179-195, 1978
23. BEEBE GW, KATO H: Review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors. II. Biological effects. E. Cancers other than leukemia. J Radiat Res 16:97-107, 1975
24. ARMENIAN HK, LILIENFELD AM: The distribution of incubation periods of neoplastic diseases. Am J Epidemiol 99:92-100, 1974
25. HEMPELMANN LH, HALL WJ, PHILLIPS M, et al: Neoplasms in persons treated with X-rays in infancy: Fourth survey in 20 years. J Natl Cancer Inst 55:519-530, 1975
26. JENSEN RD, DRAKE RM: Rarity of Ewing’s tumour in Negroes. Lancet 1:777, 1970
27. MULVIHILL JJ, GRALNICK HR, Whang-Peng J, et al: Multiple childhood osteosarcomas in an American Indian family with erythroid macrocytosis and skeletal anomalies. Cancer 40: 3115-3122, 1977
28. KITCHIN FD, ELLSWORTH RM: Pleiotropic effects of the gene for retinoblastoma. J Med Genet 11:244-246, 1974
29. ABRAMSON DH, ELLSWORTH RM, ZIMMERMAN LE: Nonocular cancer in retinoblastoma survivors. Trans Am Acad Ophthalmol Otolaryngol 81:OP454-OP457, 1976
30. TEFFT M, VAWTER GF, MITUS A: Second primary neoplasms in children. AJR 103:800-822, 1968
31. ARLEN M, HIGINBOTHAM NL, Huvos AG, et al: Radiation-induced sarcoma of bone. Cancer 28:1087-1099, 1971
32. LEWIS RJ, MARCOVE RC, ROSEN G: Ewing’s sarcoma-functional effects of radiation therapy. J Bone Joint Surg 59A:325-331, 1977
33. LI FP: Second malignant tumors after cancer in childhood. Cancer 40:1899-1902, 1977
34. ZUCKER JM, Henry-Amar M: Therapeutic controlled trial in Ewing’s sarcoma. Eur J Cancer 13:1019-1023, 1977
35. SIRSAT MV: Some uncommon tumours in childhood. Indian J Child Health 10:7-11, 1961
36. BHANSALI SK, DESAI PB: Ewing’s sarcoma. J Bone loint Surg 45A:541-553, 1963
37. LICHTENSTEIN L: Ewing’s sarcoma. In Bone Tumors, 3d ed. St. Louis: Mosby, 1965, pp 241-260
38. SMITHSON WA, BURGERT EO JR, CHILDS DS, et al: Acute myelo-monocytic leukemia after irradiation and chemotherapy for Ewing’s sarcoma. Mayo Clin Proc 53:757-759, 1978
39. HATFIELD PM, SCHULZ MD: Postirradiation sarcoma. Radiology 96:593-602, 1970
40. SIEBER SM, ADAMSON RH: The clastogenic, mutagenic, terato genic and carcinogenic effects of various antineoplastic agents. In Pharmacological Basis of Cancer Chemotherapy. Baltimore: Williams & Wilkins, 1975, pp 401-468
41. CANELLOS GP, DEVITA VT, ARSENEAU JC, et al: Second malig nancies complicating Hodgkin’s disease in remission. Lancet 1:947-949, 1975
42. BRODY RS, SCHOTTENFELD D, REID A: Multiple primary cancer risk after therapy of Hodgkin’s disease. Cancer 40:1917-1926, 1977
43. COLEMAN CN, WILLIAMS CJ, FLINT A, et al: Hematologic neo plasia in patients treated for Hodgkin’s disease. N Engl J Med 297:1249-1252, 1977
44. CADMAN EC, CAPIZZI RL, BERTINO JR: Acute nonlymphocytic leukemia. A delayed complication of Hodgkin’s disease therapy: Analysis of 109 cases. Cancer 40:1280-1296, 1977
45. D’Angio GJ, MEADOWS A, MIKE V, et al: Decreased risk of radi ation-associated second malignant neoplasm in actinomy-cin-D-treated patients. Cancer 37:1177-1185, 1976
46. WALDER BK, ROBERTSON MR, JEREMY D: Skin cancer and im munosuppression. Lancet 2:1282-1283, 1971
47. LOWRY WS, CLARK DA, HANNEMANN JH: Skin cancer and im munosuppression. Lancet 1:1290-1291, 1972
48. MARSHALL VC: Skin tumours in immunosuppressed patients. Aust NZ J Surg 43:214-223, 1973
49. KORANDA FC, DEHMEL EM, KAHN G, et al: Cutaneous complica tions in immunosuppressed renal homograft recipients. JAMA 229:419-424, 1974
50. SABANAS AO, DAHLIN DC, CHILDS DS, et al: Postradiation sar coma of bone. Cancer 9:528-542, 1956
51. CRUZ M, COLEY BL, STEWART FW: Postradiation bone sarcoma. Cancer 10:72-88, 1957
52. STEINER GC: Postradiation sarcoma of bone. Cancer 18:603-612, 1965